Use of an online community to develop patient-reported outcome instruments: the Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ).
BACKGROUND
Patients with multiple sclerosis (MS) may face barriers, such as treatment fatigue, memory problems, or side effects, that may influence their adherence to medication.


OBJECTIVE
The objective of our study was to use an online community to develop a self-report questionnaire to quantify adherence and barriers to achieving adherence, that is specific to MS disease-modifying treatments (DMTs) and predictive of missed doses.


METHODS
A review of the scientific literature and analysis of discussions between MS patients on PatientsLikeMe.com were used to generate survey items salient to patients. Cognitive debriefing was used to refine the items. The Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ) contains 30 questions in three subscales: Barriers, Side Effects, and Coping Strategies.


RESULTS
MS patients completed an online survey (response rate: 431 of 1209 invited, 35.7%). Between 16% (14/86) and 51% (51/100) of MS patients missed at least 1 dose of their DMT in the previous 28 days, with significant between-treatment differences. The MS-TAQ Barriers scale was positively correlated with the proportion of doses missed (r = .5), demonstrating a stronger relationship between adherence and perceived barriers than was found with clinical or demographic variables (r ≈ .3). The Coping Strategies subscale was negatively correlated with missed doses (r = -.3), suggesting that use of more coping strategies is associated with higher adherence.


CONCLUSIONS
Online communities can provide domains of interest and psychometric data to more rapidly develop and prototype patient-reported outcome instruments. The MS-TAQ offers patients and clinicians a simple method for identifying barriers to adherence, which may then be targeted through interventions.
PatientsLikeMe, Research & Development, Cambridge, MA 02141, USA. pwicks@patientslikeme.com
Paul
P
Wicks
Michael
M
Massagli
Amit
A
Kulkarni
Homa
H
Dastani
D000223:Adaptation, Psychological; D000328:Adult; D019058:Community Networks; D005260:Female; D006801:Humans; D020407:Internet; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000523:psychology; D010349:Patient Compliance; D010361:Patients; D011594:Psychometrics / Q000379:methods; D057566:Self Report; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
Eur J Neurol. 2011 Jan;18(1):69-77
20561039
Mult Scler. 2007 Nov;13(9):1146-52
17967842
J Neurol. 2009 Apr;256(4):568-76
19444532
N Engl J Med. 2010 Feb 4;362(5):402-15
20089954
J Neurol. 2009 Apr;256(4):554-62
19444531
Neurology. 2003 Aug 26;61(4):551-4
12939437
N Engl J Med. 2010 Feb 4;362(5):416-26
20089960
J Med Internet Res. 2004 Sep 29;6(3):e34
15471760
BMJ. 2000 Aug 12;321(7258):405-12
10938048
N Engl J Med. 2010 Feb 4;362(5):387-401
20089952
Mult Scler. 2010 Jan;16(1):112-20
19995835
J Behav Med. 2010 Jun;33(3):219-27
20127401
J Behav Ther Exp Psychiatry. 2002 Mar;33(1):39-47
12389798
J Neurosci Nurs. 2008 Dec;40(6):350-5
19170302
Mult Scler. 2005 Apr;11(2):182-5
15794392
Mult Scler. 2006 Feb;12(1):24-38
16459717
J Neurosci Nurs. 2006 Jun;38(3):167-71
16817668
Mult Scler. 2005 Jun;11(3):306-9
15957512
Mult Scler. 2005 Jun;11(3):338-42
15957517
Mult Scler. 2005 Feb;11(1):46-50
15732266
Pharmacoepidemiol Drug Saf. 2008 Jun;17(6):565-76
18395883
Health Expect. 2011 Sep;14(3):307-20
20860775
Medscape J Med. 2008;10(9):225
19008986
J Neurol. 2007 Jul;254(7):849-53
17361342
BMC Neurol. 2008 Oct 10;8:38
18845005
Mult Scler. 2005 Oct;11(5):583-4
16193897
Mult Scler. 2007 Jul;13(6):770-5
17525097
J Med Internet Res. 2011 Jan 21;13(1):e6
21252034
Cleve Clin J Med. 2006 Jan;73(1):91-102
16444920
Nat Biotechnol. 2009 Oct;27(10):888-90
19816437
J Med Internet Res. 2010 Jun 14;12(2):e19
20542858
Semin Neurol. 2008 Feb;28(1):56-68
18256987
Am J Manag Care. 2008 Feb;14(2):71-5
18269302
J Manag Care Pharm. 2004 Jun;10(3 Suppl B):S4-11
15253684
Acta Neurol Scand. 2006 Mar;113(3):156-62
16441244
Eur J Neurol. 2011 Jan;18(1):1-2
20550560
Med Care. 2004 Mar;42(3):200-9
15076819
Ann Behav Med. 2001 Spring;23(2):125-32
11394554